News
They include budesonide, fluticasone ... can help when allergy symptoms come with mild asthma. Nasal ipratropium. This prescription nose spray helps stop an extra-runny nose but doesn't do ...
ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the US, providing a new option for treating Type I allergic reactions, including anaphylaxis ...
Corstasis Therapeutics Inc. took inspiration from Narcan when coming up for its own nasal spray. “It got me thinking, ‘What could we potentially repurpose into a nasal spray for cardiology?’” Chief ...
Get Instant Summarized Text (Gist) An engineered IgM-based monoclonal antibody delivered via nasal spray provided strong protection to mice against lethal influenza A infection, including H1N1 and ...
In our experience, Flonase Allergy Relief Nasal Spray is a highly effective allergy medication that delivers prescription-strength non-drowsy relief all day and night. We found that the nasal ...
In fact the damage was down to the repeated use of nasal decongestants, which Curtis had first used to overcome the bunged-up sensation brought on by a cold. Soon he was reaching for a spray ...
The US Food and Drug Administration (FDA) has approved dihydroergotamine (DHE) nasal powder (Atzumi, Satsuma Pharmaceuticals Inc) for the acute treatment of migraine with or without aura in adults ...
DEAR DR ROACH: I have a cold. I use two brands of nasal spray for congestion, but both say not to use them for more than three days as they may cause “rebound” congestion. Can I alternate them ...
An NHS doctor has warned specific people against using nasal sprays, warning that doing so could induce "horrible" symptoms. Nasal decongestants are widely sought after for those needing respite ...
Hosted on MSN29d
FDA approves Neurelis’ nasal spray for seizuresThe US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment of acute repetitive seizures, also referred to as seizure clusters ...
The recommended dose of Atzumi is 5.2 mg, the contents of 1 nasal device, administered into 1 nostril. The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results